Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2026-02-26 @ 12:03 PM
Study NCT ID:
NCT01708603
Status:
TERMINATED
Last Update Posted:
2020-01-06
First Post:
2012-09-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
Sponsor:
Bausch Health Americas, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-12
First Submit QC Date:
None
Study First Post Date:
2012-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-10-31
Results First Submit QC Date:
None
Results First Post Date:
2020-01-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-05-07
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-01-03
Last Update Post Date:
2020-01-06
Last Update Post Date Type:
ACTUAL